Hotte SJ,Winquist EW,Stitt L,et al.Plasma osteopontin:associations with survival and metastasis to bone in men with hormone-refactory ptostate carcinoma[J].Cancer,2002,95(3):506-512.
[2]
Bramwell VH,Doig GS,Tuck AB,et al.Serial plasma osteopontin levels have prognostic value in metastatic breast cancer[J].Clin Cancer Res,2006,12( ⅡPtⅠ):3337-3343.
[3]
Mack PC,Redman MW,Chansky K,et al.Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy:SWOG Study S0003[J].J Clin Oncol,2008,26:4771-4776.
[4]
Isa SI,Kawaguchi T,Teramukai S,et al.Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer Results from JMTO LC 0004[J].J Thorac Oncol,2009,4:1104-1110.
[5]
Ramankulov A,Lein M,Kristiansen G,et al.Elevated plasma osteopontin as marker for distant metastasis and poor survival in patients with renal cell carcinoma[J].Cancer Res Clin Oncol,2007,133(9):643-652.
[6]
Schorge JO,Drake RD,Lee H,et a1.Osteopontin as an adjunct to CAl25 in detecting recurrent ovarian cancer[J].Clin Cancer Res,2004,10(10):3474-3478.
[7]
Bralora KA,Lee H,Yusuf R,et a1.Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer [J].Gyneeol Onco1,2004,93(2):36l-365.
[8]
Denhardt DT,Noda M,O'Regan AW,et al.Osteopontin as a means to cope with environmental insults:regulation of inflammation,tisstue remodeling,and cell survival[J].Clin Invest,2001,107:1055-1061.
[9]
Celetti A,Testa D,Staibono S,et al.Overexpression of the cytokine osteopontin idetifies aggressive laryngeal sqnamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness[J].Clin Cancer Res,2005,11:8019-8027.
[10]
Rodrigues LR,Teixeira JA,Schmitt FL,et al. The role of osteoponin in tumor progression and metastasis in breast cancer [J]. Cancer Epidemiol Biomarkers Prev, 2007, 16: 1087-1097.
